ZNTL earnings date and last-quarter result: last quarter miss, P/E -2.60. Updated 2026-07-23.
Zentalis Pharmaceuticals (ZNTL) Research Hub
Zentalis Pharmaceuticals (ZNTL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.07 USD (-6.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.60, market cap 0.31B. This hub links to the full technical, earnings and options research available for ZNTL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.07 USD (-6.33%) |
| 52-week range | 2.03 USD – 5.58 USD |
| Trend regime | Range |
| 14-day RSI | 29.7 (Oversold) |
| Trailing P/E | -2.60 |
| Market cap | 0.31B |
| Dividend yield | 0.00% |
Available research for ZNTL
Covered Call on ZNTL: how it works, illustrative setup around the real 2.07 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ZNTL: how it works, illustrative setup around the real 2.07 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ZNTL: how it works, illustrative setup around the real 2.07 USD price, max profit/loss, breakeven and when to use it. Educational.
ZNTL technical analysis: range, last 2.07 USD, RSI 29.7, 52w range 2.03 USD–5.58 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ZNTL in?
Zentalis Pharmaceuticals (ZNTL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ZNTL in an uptrend or downtrend?
As of 2026-10-26, ZNTL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ZNTL's trailing P/E ratio?
ZNTL's trailing P/E is -2.60, with a market cap of 0.31B. See the earnings research page for full valuation detail.